Treatment success rate for patients treated for MDR-TB in Lithuania

Lithuania: Treatment success rate for patients treated for MDR-TB was 70.0% in 2022. ▲ Rising

Latest (2022)
70.0%
Change on year
unchanged
World rank
96th
of 163 countries
All-time high
70.0%
in 2021
All-time low
3.0%
in 2007
Years of data
18
2002–2022

Treatment success rate for patients treated for MDR-TB in Lithuania, 2002–2022

0204060802002201220222002: 392003: 362007: 32008: 262009: 302010: 292011: 432012: 412013: 402014: 162015: 522016: 562017: 632018: 692019: 682020: 652021: 702022: 70

Source: World Health Organization, Global Health Observatory.

Analysis

In 2022, treatment success rate for patients treated for mdr-tb in Lithuania stood at 70.0%. That is the highest value across all 18 years on record.

Compared with earlier readings it is up 70.7% over ten years.

Over the whole period, treatment success rate for patients treated for mdr-tb in Lithuania peaked at 70.0% in 2021 and was at its lowest, 3.0%, in 2007.

Lithuania ranks 96th of 163 countries on this measure, in the middle of the range.

The long-run direction has been consistently rising across the 18 years of available data.

Treatment success rate for patients treated for MDR-TB in Lithuania, year by year

Annual values for Treatment success rate for patients treated for MDR-TB (%) in Lithuania, 2002 to 2022.
Year Value Change
2002 39.0%
2003 36.0% -7.7%
2007 3.0% -91.7%
2008 26.0% +766.7%
2009 30.0% +15.4%
2010 29.0% -3.3%
2011 43.0% +48.3%
2012 41.0% -4.7%
2013 40.0% -2.4%
2014 16.0% -60.0%
2015 52.0% +225.0%
2016 56.0% +7.7%
2017 63.0% +12.5%
2018 69.0% +9.5%
2019 68.0% -1.4%
2020 65.0% -4.4%
2021 70.0% +7.7%
2022 70.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 26.8% 3.0% 39.0% 5
2010s 47.7% 16.0% 69.0% 10
2020s 68.3% 65.0% 70.0% 3

Countries ranked near Lithuania

  1. 96 Thailand 70.0% compare
  2. 96 Dominican Republic 70.0% compare
  3. 96 Guatemala 70.0% compare
  4. 96 Djibouti 70.0% compare

See the full ranking of 175 places →

More health data for Lithuania

All data for Lithuania →

Frequently asked questions

What is treatment success rate for patients treated for mdr-tb in Lithuania?
Treatment success rate for patients treated for mdr-tb in Lithuania was 70.0% in 2022, according to World Health Organization, Global Health Observatory.
What is the highest treatment success rate for patients treated for mdr-tb recorded in Lithuania?
The highest recorded value was 70.0% in 2021.
What is the lowest treatment success rate for patients treated for mdr-tb recorded in Lithuania?
The lowest recorded value was 3.0% in 2007.
How does Lithuania rank for treatment success rate for patients treated for mdr-tb?
Lithuania ranks 96th out of 163 countries with data for 2022.
Is treatment success rate for patients treated for mdr-tb rising or falling in Lithuania?
Over the last ten years it is up 70.7%. The long-run trend across the full record is rising.
Where does this Lithuania data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Treatment success rate for patients treated for MDR-TB in Lithuania. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 04 September 2026, from https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/lithuania/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/lithuania/">Treatment success rate for patients treated for MDR-TB in Lithuania</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed